ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017

July 5, 2017 — A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to...

First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017

July 3, 2017 — Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health...

IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017

July 3, 2017 — IBA and Philips announced in mid-June they are stepping up their combined effort for...

ASTRO Names 2017 Gold Medalists in Radiation Oncology
News | Radiation Therapy | July 03, 2017

July 3, 2017 — The American Society for Radiation Oncology (ASTRO) announced the 2017 ASTRO Gold Medalists. Søren M...

Multiple Uses for Gamma Knife to Drive Market Growth Through 2025
News | Radiation Therapy | June 29, 2017

June 29, 2017 — Due to its widespread success in treating several types of brain cancer, global market growth for...

Augmenix Announces First New Zealand Prostate Cancer Patient Treated with SpaceOAR Hydrogel
News | Patient Positioning Radiation Therapy | June 28, 2017

June 28, 2017 — Augmenix Inc. announced that the first patient in New Zealand has been treated with SpaceOAR...

ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017

June 23, 2017 — The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the...

University of Wisconsin-Madison Partners With RaySearch on RayCare OIS
News | Oncology Information Management Systems (OIMS) | June 21, 2017

June 21, 2017 — The Department of Human Oncology at the University of Wisconsin-Madison has entered into an...

IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017

June 20, 2017 — Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in...

Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017

June 19, 2017 — The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer...

stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017

The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of...

News | Image Guided Radiation Therapy (IGRT) | May 24, 2017

May 24, 2017 — The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as...

ASTRO's 59th Annual Meeting Will Explore Art and Science of Radiation Oncology
News | Radiation Therapy | May 19, 2017

May 19, 2017 — Registration has opened for the 59th Annual Meeting of the American Society for Radiation Oncology (...

Proton Monte Carlo Dose Calculation Now Part of RayStation Treatment Planning
News | Treatment Planning | May 15, 2017

May 15, 2017 — RaySearch demonstrated a new Monte Carlo dose planning feature for...

Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017

February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

February 6, 2017 — A study published in the February issue of...

Sponsored Content | Videos | Radiation Oncology | January 05, 2017

Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major...

Sponsored Content | Videos | Quality Assurance (QA) | December 20, 2016

Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central...

Somatom Confidence RT Pro, RT, radiation therapy, treatment planning
Technology | Treatment Planning | December 20, 2016

December 20, 2016 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Siemens’ Somatom...